Stock Details
FMS is Fresenius Medical Care AG & Co. KGaA's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 29.16$. Average daily volumn in 3 months 564.02k. Market cap 15.45B



Stock symbol : FMS. Exchange : NYSE. Currency : USD
Lastest price : 25.11$. Total volume : 628.57k. Market state PRE
Click reload if you want to check the lastest price on market!!!

Fresenius Medical Care AG & Co. KGaA (FMS)
Last Price
25.11$
Change
0.12
Volume
628.57k

Previous Close24.99
Open25.25
Day Range25.04-25.28
Bid24.60 x 1.3k
Ask24.63 x 1.3k
Volume628.57k
Average Volume564.02k
Market Cap15.45B
Beta0.94
52 Week Range23.29-42.13
Trailing P/E16.03
Foward P/E7.56
Dividend (Yield %)2.75%
Ex-Dividend Date2022-05-13



Financial Details


According to Fresenius Medical Care AG & Co. KGaA's financial reports the company's revenue in 2021 were 17.62B an decrease(0%) over the years 2020 revenue that were of 17.86B. In 2021 the company's total earnings were 969.31M while total earnings in 2020 were 1.16B(-3.1%).


Loading ...



Organization

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the... United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Market Cap:
15.45B
Revenue:
17.62B
Total Assets:
34.37B
Total Cash:
1.48B



News about "Fresenius Medical Care AG & Co. KGaA"

creative-financial-designs-inc-adv-purchases-new-holdings-in-fresenius-medical-care-ag-co-kgaa-nysefms-image

Creative Financial Designs Inc. ADV Purchases New Holdings in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)

Source from : Defense World - 7 hours ago

Creative Financial Designs Inc. ADV purchased a new stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) in the 1st quarter, HoldingsChannel reports. The institutional investor ...See details»


fresenius-medical-care-ag-co-kgaa-nysefms-expected-to-earn-fy2022-earnings-of-215-per-share-image

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Expected to Earn FY2022 Earnings of $2.15 Per Share

Source from : Defense World - 11 hours ago

Jefferies Financial Group analyst J. Vane-Tempest expects that the company will earn $2.15 per share for the year. Jefferies Financial Group has a “Buy” rating and a $33.70 price objective on the ...See details»


Berenberg Bank Analysts Give Fresenius Medical Care AG & Co. KGaA (ETR:FME) a €82.20 Price Target

Source from : ETF Daily News - 3 days ago

Fresenius Medical Care AG & Co. KGaA (ETR:FME – Get Rating) has been assigned a €82.20 ($86.53) price target by stock analysts at Berenberg Bank in a research report issued on Monday ...See details»


Truist Financial Lowers Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Price Target to $27.00

Source from : ETF Daily News - 8 days ago

Fresenius Medical Care AG & Co. KGaA has a one year low of $23.35 and a one year high of $42.13. The company has a market cap of $13.81 billion, a price-to-earnings ratio of 13.47, a PEG ratio of ...See details»


Fresenius Medical Care AG & Co. KGaA

Source from : dgap - 8 days ago

Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).See details»


Fresenius Medical Care AG & Co. KGaA ADR - Stock Quote FMS

Source from : Morningstar%2c Inc. - 9 days ago

In that decision, the majority of the court ruled that Marietta's decision to keep DaVita (and its key peer Fresenius Medical Care) out-of-network for Marietta's insured population did not break ...See details»


Fresenius Medical Care AG & Co. KGaA: Supreme Court Ruling Raises Uncertainty for DaVita and Fresenius

Source from : YAHOO!Finance - 8 days ago

Find the latest Fresenius Medical Care AG (FMS) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...See details»


Here's Why You Should Retain Fresenius Medical (FMS) Stock Now

Source from : Nasdaq - 16 days ago

Fresenius Medical Care AG & Co. KGaA FMS is well-poised for growth on the back of a broad range of dialysis products and services and a solid global foothold. However, stiff competition remains a ...See details»


5 Biggest Hospital Companies in the World

Source from : Insider Monkey - 24 days ago

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is another company on the list of biggest hospital companies in the world. It provides kidney-dialysis services around the globe. It does so with ...See details»


Fresenius Medical Care KGaA ADR (FMEA.SG)

Source from : Yahoo Finance - 1 month ago

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Quarter ResultsFresenius Medical Care AG & Co. KGaA: Fresenius Medical Care reports first quarter results in line with its expectations ...See details»


Fresenius Medical Care(FMS)

Source from : The Motley Fool - 27 days ago

The company makes and sells products for all forms of kidney dialysis to health-care providers throughout the world, along with providing kidney dialysis treatment and other medical ancillary ...See details»


Blood Purification Devices/Equipment/Methods Market Expected to Witness Massive Growth with a Significant CAGR of 4.19%, asserts DelveInsight

Source from : Medgadget - 28 days ago

The Global Blood Purification Devices Market was valued at USD 4.90 billion in 2021, growing at a CAGR of 4.19% during the forecast period from 2022 to 2027, to reach USD 6.27 billion by 2027.See details»


Fresenius Medical Care AG & Co. KGaA

Source from : Wall Street Journal - 7 days ago

Lundbeck A/S, Dentsply Sirona, Inc. A. Gregory Sorensen Member-Supervisory Board Fresenius Medical Care AG & Co. KGaA, Empresa de Servicios Sanitarios de Los Lagos SA, IMRIS, Inc., Fusion ...See details»


Here's Why You Should Retain Fresenius Medical (FMS) Stock Now

Source from : Yahoo Finance - 15 days ago

Fresenius Medical Care AG & Co. KGaA FMS is well-poised for growth on the back of a broad range of dialysis products and services and a solid global foothold. However, stiff competition remains a ...See details»